Stockreport

Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors
PDF $225 million funded at closing, with an additional $225 million warrant tranche Financing funds operations through anticipated Phase 3 MASH 52-week data readout Finan [Read more]